ArticleCancer medicine2019

Concomitant TP53 mutations with response to crizotinib treatment in patients with ALK-rearranged non-small-cell lung cancer.

Peng Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.